United States · FDA National Drug Code directory
Lifitegrast
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59651-450_1d4b4b61-79da-4b6f-bb19-056d111bf400
- Product NDC
- 59651-450
- Form
- FOR SOLUTION
- Composition / generic term
- Lifitegrast
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20231107
- Source listing expiry
- 20261231
Source-listed ingredients
- LIFITEGRAST — 50 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 60 POUCH in 1 CARTON (59651-450-60) / 5 AMPULE in 1 POUCH (59651-450-05) / .2 mL in 1 AMPULE · 59651-450-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →